MARTIN v. ACTAVIS PHARMA, INC.

Nos. 22-2664, 22-2675.

71 F.4th 617 (2023)

Brad MARTIN, Plaintiff-Appellant, v. ACTAVIS PHARMA, INC.; Actavis Laboratories UT, Inc.; and Actavis, Inc., Defendants-Appellees.

United States Court of Appeals, Seventh Circuit.

Decided June 20, 2023.


Attorney(s) appearing for the Case

James Griffin O'Brien , Attorney, Bey & Associates, LLC, Atlanta, GA, for Plaintiff-Appellant.

Jeffrey D. Geoppinger , Jeffrey F. Peck , Attorney, Ulmer & Berne LLP, Cincinnati, OH, Andrew C. Lawrence , Darina Merriam , Erin Murphy , Attorneys, Clement & Murphy, PLLC, Alexandria, VA, for Defendants-Appelles in No. 22-2664.

Jeffrey D. Geoppinger , Ulmer & Berne LLP, Cincinnati, OH, Andrew C. Lawrence , Darina Merriam , Erin Murphy , Attorneys, Clement & Murphy, PLLC, Alexandria, VA, for Defendants-Appellees in No. 22-2675.

Before Flaum, St. Eve, and Pryor, Circuit Judges.


Plaintiff Brad Martin was taking a testosterone replacement therapy drug ("TRT") called Androderm when he suffered a heart attack. That made him one of hundreds of claimants who took a TRT before experiencing a significant cardiac event. The resulting lawsuits against TRTproducing pharmaceutical companies were

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases